Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe recruitment locations count was updated from 17 to 16. The Haarlem, Netherlands listing and the contact name Caroline Doornebos were removed from the Recruiting section.SummaryDifference0.5%

- Check21 days agoChange DetectedRevision label on the page was updated from v3.6.0 to v3.6.2, indicating an update to the page’s underlying software version.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded navigation/help sections to the Study Details page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). Standardized the Intervention/Treatment label formatting (Intervention/Treatment instead of Intervention / Treatment) and updated the page revision from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check42 days agoChange DetectedAn additional recruitment site in Chicago, Illinois (Investigational Site 0024) has been added. This update increases the total number of locations from 16 to 17.SummaryDifference0.4%

- Check57 days agoChange DetectedThe study's listed locations were updated from 17 to 16, with the Cincinnati, Ohio site removed from the recruitment roster. The overall location count now reflects 16 participating sites.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small internal update. This update does not appear to alter the study information or other user-facing content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.